The latest price target for Instil Bio (NASDAQ:TIL) was reported by Jefferies on January 7, 2025. The analyst firm set a price target for $52.00 expecting TIL to rise to within 12 months (a possible 147.97% upside). 16 analyst firms have reported ratings in the last year.

The latest analyst rating for Instil Bio (NASDAQ:TIL) was provided by Jefferies, and Instil Bio upgraded their buy rating.

The last upgrade for Instil Bio Inc happened on January 7, 2025 when Jefferies raised their price target to $52. Jefferies previously had a hold for Instil Bio Inc.

The last downgrade for Instil Bio Inc happened on April 12, 2024 when Jefferies changed their price target from $5 to $11 for Instil Bio Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Instil Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Instil Bio was filed on January 7, 2025 so you should expect the next rating to be made available sometime around January 7, 2026.

While ratings are subjective and will change, the latest Instil Bio (TIL) rating was a upgraded with a price target of $11.00 to $52.00. The current price Instil Bio (TIL) is trading at is $20.97, which is within the analyst’s predicted range.